To evaluate whether CX3CL1 expression is associated with disease aggressiveness with functional experiments, we evaluated the expression levels in 3 different types of cell lines, TCCSUP (grade IV cancer), 5637 (grade II cancer), and T24 cells (high-grade and invasive TCC). The gene discussed is CX3CL1; the disease is cancer.